Immunity to fungi

Current Opinion in Immunology

Volumn 18, Issue 4, 2006, Pages 465-472

  Hohl, Tobias M ^a   Rivera, Amariliz ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CD209 ANTIGEN; DECTIN 1; GAMMA INTERFERON; INTERLEUKIN 12; LAMINARAN; LECTIN RECEPTOR; MANNOSE RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; PENTRAXIN; PENTRAXIN 3; REACTIVE OXYGEN METABOLITE; RECOMBINANT ANTIBODY; TETANUS TOXOID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANDIDIASIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENTIATION; FUNGUS GROWTH; HELPER CELL; HISTOPLASMOSIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; INTERNALIZATION; MACROPHAGE; MOLECULAR MECHANICS; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANIMALS; FUNGI; HUMANS; IMMUNITY, NATURAL; MYCOSES;

EID: 33745342303     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.05.003     Document Type: Review

References (86)

1. Bennett J.E. Introduction to mycoses. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Practices and Principles of Infectious Diseases (2005), Elsevier 2935-2938
2. Romani L. Immunity to fungal infections. Nat Rev Immunol 4 (2004) 1-23
3. Patterson T.F. Advances and challenges in management of invasive mycoses. Lancet 366 (2005) 1013-1025
4. Levitz S.M. Interactions of Toll-like receptors with fungi. Microbes Infect 6 (2004) 1351-1355
5. Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., di Francesco P., and Romani L. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 168 (2002) 1362-1371
6. Romani L., Montagnoli C., Bozza S., Perruccio K., Spreca A., Allavena P., Verbeek S., Calderone R.A., Bistoni F., and Puccetti P. The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol 16 (2004) 149-161
7. Garlanda C., Hirsch E., Bozza S., Salustri A., De Acetis M., Nota R., Maccagno A., Riva F., Bottazzi B., Peri G., et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420 (2002) 182-186
8. Garlanda C., Bottazzi B., Bastone A., and Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23 (2005) 337-366
9. Diniz S.N., Nomizo R., Cisalpino P.S., Teixeira M.M., Brown G.D., Mantovani A., Gordon S., Reis L.F., and Dias A.A. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 75 (2004) 649-656
10. Lee S.J., Gonzalez-Aseguinolaza G., and Nussenzweig M.C. Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice. Mol Cell Biol 22 (2002) 8199-8203
11. Hogaboam C.M., Takahashi K., Ezekowitz R.A., Kunkel S.L., and Schuh J.M. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J Leukoc Biol 75 (2004) 805-814
12. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6 (2006) 33-43
13. Jouault T., Ibata-Ombetta S., Takeuchi O., Trinel P.A., Sacchetti P., Lefebvre P., Akira S., and Poulain D. Candida albicans phospholipomannan is sensed through Toll-like receptors. J Infect Dis 188 (2003) 165-172
14. van der Graaf C.A., Netea M.G., Verschueren I., van der Meer J.W., and Kullberg B.J. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 73 (2005) 7458-7464
15. Villamon E., Gozalbo D., Roig P., O'Connor J.E., Fradelizi D., and Gil M.L. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 6 (2004) 1-7
16. Bellocchio S., Montagnoli C., Bozza S., Gaziano R., Rossi G., Mambula S.S., Vecchi A., Mantovani A., Levitz S.M., and Romani L. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172 (2004) 3059-3069
17. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., van Krieken J.H., Hartung T., Adema G., and Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172 (2004) 3712-3718
18. Shoham S., Huang C., Chen J.M., Golenbock D.T., and Levitz S.M. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol 166 (2001) 4620-4626
19. Yauch L.E., Mansour M.K., Shoham S., Rottman J.B., and Levitz S.M. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun 72 (2004) 5373-5382
20. Biondo C., Midiri A., Messina L., Tomasello F., Garufi G., Catania M.R., Bombaci M., Beninati C., Teti G., and Mancuso G. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur J Immunol 35 (2005) 870-878
21. Balloy V., Si-Tahar M., Takeuchi O., Philippe B., Nahori M.A., Tanguy M., Huerre M., Akira S., Latge J.P., and Chignard M. Involvement of Toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect Immun 73 (2005) 5420-5425
22. Brown G.D., and Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 413 (2001) 36-37
23. •] showed that particulate β-glucan-induced signaling through the dectin-1/Syk axis might occur independently of TLR/MyD88 activation, resulting in IL-10 synthesis - a process that might play an important role in the development of Treg responses to fungal pathogens.
24. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., and Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197 (2003) 1119-1124
25. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197 (2003) 1107-1117
26. •].
27. Suram S., Brown G.D., Ghosh M., Gordon S., Loper R., Taylor P.R., Akira S., Uematsu S., Williams D.L., and Leslie C.C. Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the beta-glucan receptor. J Biol Chem 281 (2006) 5506-5514
28. Gantner B.N., Simmons R.M., and Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24 (2005) 1277-1286. During the course of mammalian infection the transition of C. albicans from yeast to the filamentous state is crucial for pathogenicity. This study demonstrated that yeast cells accumulate surface β-glucans through bud and birth scars, whereas hyphae did not. In contrast to yeast cells, hyphae failed to activate dectin-1-dependent signaling, leading to diminished macrophage antifungal effector functions.
29. •] revealed that A. fumigatus conidia provoke inflammatory responses only if fungal cells could undergo swelling, a process that led to β-glucan exposure. TLR/MyD88 and dectin-1 signaling were both activated by conidial swelling but acted independently to produce inflammatory mediators. Selective innate immune recognition of germinating conidia might provide a mechanism to limit potentially harmful inflammatory responses in the lung to conidia that represent an invasive threat.
30. •].
31. Steele C., Marrero L., Swain S., Harmsen A.G., Zheng M., Brown G.D., Gordon S., Shellito J.E., and Kolls J.K. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the dectin-1 beta-glucan receptor. J Exp Med 198 (2003) 1677-1688
32. Viriyakosol S., Fierer J., Brown G.D., and Kirkland T.N. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and dectin-1. Infect Immun 73 (2005) 1553-1560
33. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., Hirota K., Tanaka S., Nomura T., Miki I., et al. A role for fungal β-glucans and their receptor dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201 (2005) 949-960
34. Hahn P.Y., Evans S.E., Kottom T.J., Standing J.E., Pagano R.E., and Limper A.H. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J Biol Chem 278 (2003) 2043-2050
35. Lee S.J., Zheng N.Y., Clavijo M., and Nussenzweig M.C. Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect Immun 71 (2003) 437-445
36. Lam J.S., Mansour M.K., Specht C.A., and Levitz S.M. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175 (2005) 7496-7503
37. Serrano-Gomez D., Dominguez-Soto A., Ancochea J., Jimenez-Heffernan J.A., Leal J.A., and Corbi A.L. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol 173 (2004) 5635-5643
38. Cambi A., Gijzen K., de Vries J.M., Torensma R., Joosten B., Adema G.J., Netea M.G., Kullberg B.J., Romani L., and Figdor C.G. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33 (2003) 532-538
39. Caparros E, Munoz P, Sierra-Filardi E, Serrano-Gomez D, Puig-Kroger A, Rodriguez-Fernandez JL, Mellado M, Sancho J, Zubiaur M, Corbi AL: DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006. in press.
40. Philippe B., Ibrahim-Granet O., Prevost M.C., Gougerot-Pocidalo M.A., Sanchez Perez M., Van der Meeren A., and Latge J.P. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 71 (2003) 3034-3042
41. Marr K.A., Balajee S.A., Hawn T.R., Ozinsky A., Pham U., Akira S., Aderem A., and Liles W.C. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 71 (2003) 5280-5286
42. Bellocchio S., Moretti S., Perruccio K., Fallarino F., Bozza S., Montagnoli C., Mosci P., Lipford G.B., Pitzurra L., and Romani L. TLRs govern neutrophil activity in aspergillosis. J Immunol 173 (2004) 7406-7415
43. Taylor P.R., Brown G.D., Reid D.M., Willment J.A., Martinez-Pomares L., Gordon S., and Wong S.Y. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169 (2002) 3876-3882
44. Shao X., Mednick A., Alvarez M., van Rooijen N., Casadevall A., and Goldman D.L. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 175 (2005) 3244-3251. Using chlodronate instillation to deplete alveolar macrophage levels, the authors demonstrated that macrophages acted, in a species-specific manner, either to promote host defense and fungal clearance or to exacerbate disease progression and fungal persistence. Differences in outcome correlated with intrinsic differences in anti-cryptococcal effector functions found in murine and rat alveolar macrophages.
45. Kelly R.M., Chen J., Yauch L.E., and Levitz S.M. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun 73 (2005) 592-598
46. Hogaboam C.M., Blease K., Mehrad B., Steinhauser M.L., Standiford T.J., Kunkel S.L., and Lukacs N.W. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156 (2000) 723-732
47. Hernandez Y., Arora S., Erb-Downward J.R., McDonald R.A., Toews G.B., and Huffnagle G.B. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 174 (2005) 1027-1036
48. Noverr M.C., Falkowski N.R., McDonald R.A., McKenzie A.N., and Huffnagle G.B. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 73 (2005) 30-38
49. Bozza S., Perruccio K., Montagnoli C., Gaziano R., Bellocchio S., Burchielli E., Nkwanyuo G., Pitzurra L., Velardi A., and Romani L. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102 (2003) 3807-3814
50. Shao C., Qu J., He L., Zhang Y., Wang J., Zhou H., Wang Y., and Liu X. Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes Immun 6 (2005) 103-114
51. Shao C., Qu J., He L., Zhang Y., Wang J., Wang Y., Zhou H., and Liu X. Transient overexpression of gamma interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis. Clin Exp Immunol 142 (2005) 233-241
52. Filler S.G., Yeaman M.R., and Sheppard D.C. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 41 (2005) S208-S212
53. Herring A.C., Falkowski N.R., Chen G.H., McDonald R.A., Toews G.B., and Huffnagle G.B. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect Immun 73 (2005) 39-49
54. Carpenter K.J., and Hogaboam C.M. Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis. Infect Immun 73 (2005) 7198-7207
55. Morrison B.E., Park S.J., Mooney J.M., and Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 112 (2003) 1862-1870
56. Shao X., Rivera J., Niang R., Casadevall A., and Goldman D.L. A dual role for TGF-β1 in the control and persistence of fungal pneumonia. J Immunol 175 (2005) 6757-6763
57. Berkova N., Lair-Fulleringer S., Femenia F., Huet D., Wagner M.C., Gorna K., Tournier F., Ibrahim-Granet O., Guillot J., Chermette R., et al. Aspergillus fumigatus conidia inhibit tumour necrosis factor- or staurosporine-induced apoptosis in epithelial cells. Int Immunol 18 (2006) 139-150
58. Bozza S., Fallarino F., Pitzurra L., Zelante T., Montagnoli C., Bellocchio S., Mosci P., Vacca C., Puccetti P., and Romani L. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 174 (2005) 2910-2918
59. Mednick A.J., Nosanchuk J.D., and Casadevall A. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 73 (2005) 2012-2019
60. Chen G.H., McDonald R.A., Wells J.C., Huffnagle G.B., Lukacs N.W., and Toews G.B. The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect Immun 73 (2005) 1788-1796
61. Arora S., and Huffnagle G.B. Immune regulation during allergic bronchopulmonary mycosis: lessons taught by two fungi. Immunol Res 33 (2005) 53-68
62. Scheckelhoff M., and Deepe Jr. G.S. A deficiency in gamma interferon or interleukin-10 modulates T-cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun 73 (2005) 2129-2134
63. Deepe Jr. G.S., and Gibbons R.S. T cells require tumor necrosis factor-α to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis 193 (2006) 322-330
64. •] but also T cell and antibody host responses.
65. + T cells during Cryptococcus neoformans infection. J Immunol 174 (2005) 7920-7928
66. Lin J.S., Yang C.W., Wang D.W., and Wu-Hsieh B.A. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J Immunol 174 (2005) 6282-6291
67. + T cells are effector cells against pneumocystis in mice. J Immunol 172 (2004) 1132-1138
68. Ramadan G., Davies B., Kurup V.P., and Keever-Taylor C.A. Generation of cytotoxic T cell responses directed to human leucocyte antigen class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 140 (2005) 81-91
69. Montagnoli C., Fallarino F., Gaziano R., Bozza S., Bellocchio S., Zelante T., Kurup W.P., Pitzurra L., Puccetti P., and Romani L. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 176 (2006) 1712-1723
70. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., Joosten L.A., Akira S., Netea M.G., and Adema G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116 (2006) 485-494
71. Casadevall A., Feldmesser M., and Pirofski L.A. Induced humoral immunity and vaccination against major human fungal pathogens. Curr Opin Microbiol 5 (2002) 386-391
72. Lopez-Ribot J.L., Casanova M., Murgui A., and Martinez J.P. Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol 41 (2004) 187-196
73. Torosantucci A., Bromuro C., Chiani P., De Bernardis F., Berti F., Galli C., Norelli F., Bellucci C., Polonelli L., Costantino P., et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202 (2005) 597-606. The authors designed a vaccine that generates β-glucan-specific antibodies that can provide immunity to Candida and Aspergillus infections in preclinical animal studies without the need for cell-mediated killing mechanisms. The promise of this approach is the induction or infusion of anti-β-glucan antibodies that have antifungal effector properties for prophylactic benefit in vulnerable hosts or for therapeutic benefit in infected hosts.
74. Biondo C., Messina L., Bombaci M., Mancuso G., Midiri A., Beninati C., Cusumano V., Gerace E., Papasergi S., and Teti G. Characterization of two novel cryptococcal mannoproteins recognized by immune sera. Infect Immun 73 (2005) 7348-7355
75. Martinez L.R., and Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73 (2005) 6350-6362
76. Empey K.M., Hollifield M., Schuer K., Gigliotti F., and Garvy B.A. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation. Infect Immun 72 (2004) 6211-6220
77. + T cells for use as cellular therapy in high-risk patients.
78. + T cells from haploidentical donors to allogeneic stem cell transplant recipients. Recipients tolerated the T cell graft without development of graft-versus-host disease at the transferred dose, and demonstrated a therapeutic benefit.
79. BitMansour A., Cao T.M., Chao S., Shashidhar S., and Brown J.M. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood 105 (2005) 3535-3537. The authors investigated the protective effect of myeloid-committed progenitor cells to mice infected with A. fumigatus during chemotherapy-induced neutropenia. This preclinical study demonstrated that progenitors entered the bone marrow, differentiated into neutrophils, and migrated to sites of infection, which resulted in enhanced survival.
80. Gaziano R., Bozza S., Bellocchio S., Perruccio K., Montagnoli C., Pitzurra L., Salvatori G., De Santis R., Carminati P., Mantovani A., et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 48 (2004) 4414-4421
81. Matthews R.C., Rigg G., Hodgetts S., Carter T., Chapman C., Gregory C., Illidge C., and Burnie J. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother 47 (2003) 2208-2216
82. Larsen R.A., Pappas P.G., Perfect J., Aberg J.A., Casadevall A., Cloud G.A., James R., Filler S., and Dismukes W.E. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated Cryptococcal meningitis. Antimicrob Agents Chemother 49 (2005) 952-958
83. Mansour M.K., Yauch L.E., Rottman J.B., and Levitz S.M. Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infect Immun 72 (2004) 1746-1754
84. Maitta R.W., Datta K., Lees A., Belouski S.S., and Pirofski L.A. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect Immun 72 (2004) 196-208
85. Ibrahim A.S., Spellberg B.J., Avenissian V., Fu Y., Filler S.G., and Edwards Jr. J.E. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73 (2005) 999-1005
86. Chaturvedi A.K., Kavishwar A., Shiva Keshava G.B., and Shukla P.K. Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis. Clin Diagn Lab Immunol 12 (2005) 1063-1068